Literature DB >> 24336544

Is diabetes a coronary artery disease equivalent?

Ricky D Turgeon, Hoan Linh Banh, Christina Korownyk.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24336544      PMCID： PMC3860928     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.

Authors:  S Goya Wannamethee; A Gerald Shaper; Peter H Whincup; Lucy Lennon; Naveed Sattar
Journal:  Arch Intern Med       Date:  2011-03-14

2.  Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.

Authors:  Barbara V Howard; Lyle G Best; James M Galloway; William James Howard; Kristina Jones; Elisa T Lee; Robert E Ratner; Helaine E Resnick; Richard B Devereux
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

Review 3.  Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Authors:  João Costa; Margarida Borges; Cláudio David; António Vaz Carneiro
Journal:  BMJ       Date:  2006-04-03

4.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

Review 5.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Authors:  Todd J Anderson; Jean Grégoire; Robert A Hegele; Patrick Couture; G B John Mancini; Ruth McPherson; Gordon A Francis; Paul Poirier; David C Lau; Steven Grover; Jacques Genest; André C Carpentier; Robert Dufour; Milan Gupta; Richard Ward; Lawrence A Leiter; Eva Lonn; Dominic S Ng; Glen J Pearson; Gillian M Yates; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2013-02       Impact factor: 5.223

6.  Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Authors:  Tina Ken Schramm; Gunnar H Gislason; Lars Køber; Søren Rasmussen; Jeppe N Rasmussen; Steen Z Abildstrøm; Morten Lock Hansen; Fredrik Folke; Pernille Buch; Mette Madsen; Allan Vaag; Christian Torp-Pedersen
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

Review 7.  Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

Authors:  Jeffrey S Berger; David L Brown; Richard C Becker
Journal:  Am J Med       Date:  2008-01       Impact factor: 4.965

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 9.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors:  Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal:  BMJ       Date:  2009-11-06

Review 10.  Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Yurong Zhang; Gang Hu; Zuyi Yuan; Liwei Chen
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.